Achieve Life Science Inc. (ACHV)

[cjstocksup]

Only fools short a 1.2 million share float approx. heading into a CC and a medical conference. We already had a 35% short position it will kill them once we cross $20.00 and $30.00 etc.
ACHV is heading into a 21 billion dollar market with our new drug. Do some DD! We are way undervalued even at $50.00 IMO.

[Disquisition]

DOWN to 11.51 already

[cjstocksup]

Very few shares traded lock up all ACHV shares with GTC sell orders at $50.00 and get ready for next week. Plus we have the conference in about 2 weeks. IMO we can see $50.00 with the right investors soon. This AM is alot of shorting on a RS but they do not get most low float reverse splits can run several hundred percent above with ease. Let them short it they are going to get killed again very soon IMO! I am adding this AM.

[Disquisition]

standing by for the DUMPING to begin today.

Wouldn’t be surprised to be below $10 by EOD.

All those shares out there from the OFFERING last month just waiting to be DUMPED

[cjstocksup]

Agreed tiny just over 1 million share ACHV float should easily see $50.00 just ahead maybe today if we follow yesterdays hot RS TAOP IMO we are worth far more than even $50.00 ahead.

think we will see $30...50 next week
before cc

[peterus]

think we will see $30...50 next week
before cc

[cjstocksup]

I expect a solid run through $20.00 and if we get volume to $50.00 with this tiny float now.
ACHV

[peterus]

6 aug cc should go upppp

[peterus]

will go down first Buying the dips

[cjstocksup]

ACHV has no dilution, cash on hand and only did the RS to be Nasdaq compliant with their big drug coming to market that is bigger than Chantix. If anyone is having troubles adding, buying etc. or trading call your brokers so they will speed up trading before the open of the markets. Based on yesterday we should open between $12.00 and $18.00 to start trading. cytisinicline is a multi billion dollar drug!

Over the past decade or so, we’ve seen a big push to get smokers to quit smoking cigarettes. However, doing so is very difficult. In order to fight the addiction, smokers spend more than $21 billion annually on products that are designed to help them quit.

With that ACHV is working on a smoking cessation product known as cytisinicline, and has had some pretty strong success. In fact, about a month ago, the company released the results from an investigator-initiated study that compared cytisinicline to the top smoking cessation drug on the market, Chantix.

Importantly, cytisinicline outperformed Chantix, setting the stage for the company to push toward commercialization with a drug that represents a multi-billion dollar opportunity.

So, even without the short squeeze, the promise offered through cytisinicline suggests that you should be paying close attention to ACHV stock.

[cjstocksup]

ACHV with the tiny float could see $50.00 today based on that huge floater TAP the Chinese scam stock that ran over 3000% yesterday after their smaller RS. There will be limited shares only shorts will be active early like then KABOOM above IMO. TAOP had to trade nearly 100 million shares to do what they did! A little over 1 million shares in our ACHV float should be awesome ahead.

close was 0.6
$12 tmrw

[peterus]

close was 0.6
$12 tmrw

[cjstocksup]

Afterhours was .66 that would be almost $13.00 tomorrow morning. The ACHV float will be much lower if they are doing the split tonight. If not we are off to the races anyway because that means they will wait the next 6 months hopefully to just get back over $1.00. That could have happened this week if it had not been for all the RS panic sellers and shorts today. We ran to .82 plus this AM with ease until the fools hit. Based on yesterdays close we should open at $12.00 or much more if the RS is 20 to 1. Now if they run it like they ran TAOP today then we could run to $30.00 plus etc. That one went insane on huge volume. We would not even need that kind of volume. Plus those Chinese stocks are scams. ACHV is legit with a multi billion dollar drug.

[JoeWo]

Gets rid of the exchange Deficiency (D).

[JoeWo]

Purely in my opinion--> Some institutional investors are prohibited from buying stocks under $5 a share. Since the reverse split is taking place one week prior to earnings and drug update, it is my contention that the company wants as many investors to come on board after the news is announced. Then the morning after, the stock will skyrocket, but then the next day another dilution round will be announced.
I will keep this until the morning after earnings are announced and then sell at 9:40 after the big run up, before the sell-off and dilution.
my plan. GLTA.

[JoeWo]

Reverse splits can signal good news for investors or bad news. A reverse split can signal that a company is financially strong enough to be listed on an exchange. The stock price will increase enough to meet the exchange’s minimum price requirement. If you own stock in a small company that has seen increased sales and profits, the stock price should continue to rise after the reverse split.
Stocks newly listed on an exchange can attract new buyers, especially institutional investors who avoid over-the-counter and pink sheets stocks. Although you will end up owning fewer shares, they will be worth more as the price continues to rise.

[ClayTrader]

* * $ACHV Video Chart 07-30-2020 * *

Link to Video - click here to watch the technical chart video

[420man]

Next leg will up incoming... Gonna be a solid run here :)

[Jess070283]

Squeeze em!

[420man]

Hold on...huge run incoming. 3.1 million short on a Thursday AH's! BOOM! Shorty KNOWS it's time to cover...make them PAY!

[420man]

Reloaded .60

[cjstocksup]

ACHV Beyond The Short Squeeze
The fact of the matter is that while the short squeeze is driving attention for Achieve Life Sciences, the company represents a strong opportunity outside of the squeeze. It has to do with smoking.

Over the past decade or so, we’ve seen a big push to get smokers to quit smoking cigarettes. However, doing so is very difficult. In order to fight the addiction, smokers spend more than $21 billion annually on products that are designed to help them quit.

With that ACHV is working on a smoking cessation product known as cytisinicline, and has had some pretty strong success. In fact, about a month ago, the company released the results from an investigator-initiated study that compared cytisinicline to the top smoking cessation drug on the market, Chantix.

Importantly, cytisinicline outperformed Chantix, setting the stage for the company to push toward commercialization with a drug that represents a multi-billion dollar opportunity.

So, even without the short squeeze, the promise offered through cytisinicline suggests that you should be paying close attention to ACHV stock.

[daisyfresh]

Okay.

[cjstocksup]

If you want to see what can happen a day after a RS look at TAOP today. ACHV will have a tiny float and we are heading into news and events.

[JoeWo]

Angry shorts doubling down.

[daisyfresh]

Sinkin' and stinkin'.

[daisyfresh]

This stink bomb stock is finished then?

[JoeWo]

Looking forward to that MOASS.
August 6 earnings coming up with a drug update too.
After the RS, then it will no longer be considered a penny stock and then more funds, etc. can buy it after the good news comes out.

[Nickyzen]

Holding ACHV ...not going to sell...there is going to be lot of positive stuffs in the coming days

[cjstocksup]

It will help the stock to have such a tiny float with our drug that is far bigger than Chantix. Plus there would be a major MOASS ahead. Some of my largest stock gains happened in stocks after a RS. They voted for it 2 months back because of the stock price and Nasdaq rules for the PPS etc.

[peterus]

lol bro its on the website sec filings

[daisyfresh]

The Company’s board of directors has determined to set the reverse stock split ratio at 1-for-20. The effective date of the reverse stock split is July31, 2020, and the shares will begin trading on a split-adjusted basis on July 31, 2020

[JoeWo]

RS not on the corporate website.

https://achievelifesciences.com/news/

[peterus]

website achv

[Nickyzen]

Do you have any link to prove ? Is there any filing?

[peterus]

higher but with r/s tmrw 20/1

[cjstocksup]

I agree. ACHV $2.00 should be soon.

Analyst Consensus: The average price Target is $6.00 with a high estimate of $10.00 and low estimate of $2.00. Having my bro @Lionmaster in here will only make us get to the $2.00 faster.
$ACHV

[cjstocksup]

Great article on what we have to look forward to with ACHV. I think we see a couple dollars soon. It was sure fun seeing $1.30 pre market yesterday, let's see what we can do today!
https://alphastocknews.com/ahieve-life-sciences-achv-stock-rockets-heres-why/3864/

[seattle1980]

Money.cnn.com. You may be right, I am just posting what I read on CNN site.I think that we should get to $2 within days....that's all I want... $ACHV

[xgin]

The analyst I'd throw out is Wainwright or whatever. Their estimates usually have no relationship to fact.

[seattle1980]

Analyst Consensus: The average price Target is $6.00 with a high estimate of $10.00 and low estimate of $2.00. Having my bro @Lionmaster in here will only make us get to the $2.00 faster.
$ACHV

[xgin]

https://alphastocknews.com/ahieve-life-sciences-achv-stock-rockets-heres-why/3864/ Good read!

[ClayTrader]

* * $ACHV Video Chart 07-29-2020 * *

Link to Video - click here to watch the technical chart video

[xgin]

Nope he's still buying in AH.

[JoeWo]

The 2020 SRNT E-conference will be held in Lausanne, Switzerland, on 17-19 September 2020.

Earnings and drug update on August 6.

[Jess070283]

Might be a huge runner today. In on dip!$$

[cjstocksup]

I love ACHV! I see we ran to $1.30 pre market. Looking forward to the days ahead.

[peterus]

its was 100%
everybody would sell

[maximumgriff]

Lion must be sellin

[xgin]

Look who's in the stock.
Lionmaster
4m
$ACHV please don’t short low price pennies it’s insane to not doing DD. We have a blockbuster smoking cessation “drug” phase 3 data to be released soon and the interim data just out it was shown to leapfrog Chantix which is a $3B sales per year blockbuster. 2 analysts recently raised their PT to $2. $IBIO $HTBX $VXRT $INO